Destiny Wealth Partners, LLC Astrazeneca PLC Transaction History

Destiny Wealth Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 26, 2023	SELL	$54.21 - $70.44 $27,159 - $35,290	-501 Reduced 60.87%	322 $0
Q2 2022 Jul 15, 2022	BUY	$59.26 - $71.14 $48,770 - $58,548	823 New	823 $54,000
Q4 2021 Jan 20, 2022	SELL	$54.02 - $63.83 $3,187 - $3,765	-59 Closed	0 $0
Q3 2021 Oct 28, 2021	BUY	$55.56 - $60.79 $3,278 - $3,586	59 New	59 $4,000
Q1 2021 Apr 22, 2021	SELL	$47.16 - $54.44 $3,536 - $4,083	-75 Closed	0 $0
Q4 2020 Feb 05, 2021	BUY	$48.52 - $58.02 $3,639 - $4,351	75 New	75 $4,000

1,334

476M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $218B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Destiny Wealth Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Destiny Wealth Partners, LLC with notifications on news.